TITLE

THE THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION

AUTHOR(S)
Poliwoda, Hubert
PUB. DATE
August 1966
SOURCE
Angiology;Aug1966, Vol. 17 Issue 8, p528
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the thrombolytic therapy of acute myocardial infarction. Recanalization of the thrombolitically narrowed or occluded coronary artery; Prevention of thrombosis in a functioning collateral circulation; Maintenance of the microcirculation in the outer zone of the infarction area.
ACCESSION #
16378171

 

Related Articles

  • Does Increased Lipoprotein (a) Impair the Effectiveness of Thrombolysis With Streptokinase? Tokgözoǧlu, S. Lale; Özmen, Ferhan; Kabukçu, Mehmet; Karanfil, Aydin; Aytemir, Kudret; Özkuyumcu, Cumhur; Ugurlu, Şevket // Angiology;Aug1995, Vol. 46 Issue 8, p727 

    Although lipoprotein (a) [Lp(a)] has been shown to interfere with thrombolysis in vitro, its effects on thrombolytic therapy in patients with acute myocardial infarction (MI) are not clear. The authors evaluated 32 male patients ages thirty-five to seventy-five (mean fifty-two ± ten) with the...

  • SHOULD PATIENTS WITH ACUTE ST ELEVATION MI BE TRANSFERRED FOR PRIMARY PCI? Kristensen, S. D.; Andersen, H. R.; Thuesen, L.; Krusell, L. R.; B&3x00F8;tker, H. E.; Lassen, J. F.; Nielsen, T. T. // Heart;Nov2004, Vol. 90 Issue 11, p1358 

    The article focuses on the suitability of primary percutaneous coronary intervention (PCI) in acute myocardial infarction (MI). Mechanical reperfusion with PCI in acute MI was first performed in the beginning of the 1980s. During the next decade pioneer work, results revealed that primary PCI...

  • Primary percutaneous coronary intervention in acute myocardial infarction: time, time, and time! Steg, P. G.; Juliard, J-M. // Heart;Aug2005, Vol. 91 Issue 8, p993 

    Focuses on the impact of time and delays on the outcome after primary percutaneous coronary intervention (PCI). Relationship between delay between admission and actual inflation of the PCI balloon in the coronary arteries and patient mortality; Decrease in the benefits of intravenous...

  • Recent advances in primary percutaneous intervention for acute myocardial infarction. Smith, E. J.; Mathur, A.; Rothman, M. T. // Heart;Dec2005, Vol. 91 Issue 12, p1533 

    The article presents a discussion on the recent advances in primary percutaneous intervention (PPCI) for acute myocardial infarction (AMI). Interventional cardiology has evolved since the first studies comparing PPCI and intravenous thrombolysis for the treatment of ST segment elevation...

  • The Relationship between Collateral Blood Flow and Infarct Zone Regional Wall Motion in Patients with Recent Acute Myocardial Infarction. Sezer, Murat; Nisanci, Yilmaz; Umman, Berrin; Erdogan, Dogan; Umman, Sabahattin; Ozsaruhan, Onat // International Journal of Angiology (Springer Science & Business ;Spring2003, Vol. 12 Issue 2, p114 

    After acute myocardial infarction (AMI), the most significant prognostic determinants of myocardial viability and function are deterioration degree of the distal myocardial microcirculation and collateral flow. Quantification of coronary collateral circulation is possible by using intracoronary...

  • Microvascular perfusion 1 week and 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging. Bodi, V.; Sanchis, J.; López-Lereu, M. P.; Nüñez, J.; Sanz, R.; Palau, P.; Gómez, C.; Moratal, D.; Chorro, F. J.; Llácer, A. // Heart;Dec2006, Vol. 92 Issue 12, p1801 

    Objective: To characterise the evolution of myocardial perfusion during the first 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging (CMR) and determine its significance. Design: Prospective cohort design. Setting: Single-centre study in a...

  • The Efficacy Of Thrombolytic Treatment On Patients Who Are Above 75 Years Of Age. Keles, Telat; Akar, Nihal; Gürsel, Koray; Canbay, Alper; Sahin, Deniz; Durmaz, Tahir; Diker, Erdem; Aydogdu, Sinan // Internet Journal of Cardiology;2006, Vol. 3 Issue 1, p2 

    Background: For acute myocardial infarction (AMI) patients above the age of 75, the efficacy of thrombolytic treatment could not be demonstrated clearly. Recently, depending on the data obtained from observational studies, it has been advocated that thrombolytic treatment might not be showing...

  • An estimation of the efficiency of thrombolytic therapy in patients with myocardial infarction. Strelcenia, Margarita; Gubkin, S. V. // International Journal of Collaborative Research on Internal Medi;May2012, Vol. 4 Issue 5, p780 

    Introduction: Myocardial infarction (MI) is the most prognostic terrible disease. It is caused by the blockage of a coronary artery by a thrombus or clot. This is usually the result of a rupture of an atherosclerotic plaque within the artery. The heart muscle supplied by that artery is damaged...

  • Fibrinolytic Therapy Urokinase for Myocardial Infarction. Nakano, Minoru // Angiology;Oct1983, Vol. 34 Issue 10, p654 

    The article reports on fibrinolytic therapy urokinase (UK) for myocardial infarction. UK is believed to lyse thrombi appearing in the coronary artery and to prevent the extension of infarct by inhibiting the occurrence of secondary thrombi. The author has reported the results of previous studies...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics